News
- Author:
- Roxanne Nelson
Publish date: November 20, 2017
Anticancer agents may be more active after transplantation than before, researchers suggested.
News
- Author:
- Roxanne Nelson
Publish date: November 10, 2017
Compared with other red blood cell products, those derived from apheresis significantly increased pulmonary cell interleukin-6 and interleukin-8 pr...
News
- Author:
- Roxanne Nelson
Publish date: November 5, 2017
PBT increased the risk of tumor recurrence, metastatic progression, and death in patients undergoing nephrectomy for RCC.
News
- Author:
- Roxanne Nelson
Publish date: November 2, 2017
Event-free survival at 24 months (EFS24) is predictive of survival in patients with peripheral T-cell lymphomas (PTCLs), according to new findings ...
News
- Author:
- Roxanne Nelson
Publish date: October 30, 2017
SAN DIEGO – As measured by chest drain output after chest closure, patients who received cold stored platelets had a significantly lower median amo...
News
- Author:
- Roxanne Nelson
Publish date: October 26, 2017
SAN DIEGO – Prophylactic oral or intravenous calcium supplements can correct decreased ionized calcium levels and manage the symptoms of hypocalcem...
News
- Author:
- Roxanne Nelson
Publish date: October 26, 2017
SAN DIEGO – Accepted donors with tattoos increased 13-fold in California and 3-fold in Arizona after statewide regulations were enacted.
News
- Author:
- Roxanne Nelson
Publish date: October 25, 2017
The rates of deferral were evaluated in two 7-month periods before and after the policy change.
News
- Author:
- Roxanne Nelson
Publish date: October 25, 2017
If HLA testing is not performed in these cases, male blood recipients can potentially be placed at risk.
News
- Author:
- Roxanne Nelson
Publish date: September 29, 2017
Could the phase-2 PYRAMID trial’s bortezomib dosing explain the lack of significant benefit?
News
- Author:
- Roxanne Nelson
Publish date: September 15, 2017
Overall survival with eribulin was 15.6 versus 8.4 months with dacarbazine in a phase 3 randomized trial of 452 patients with advanced liposarcoma....
News
- Author:
- Roxanne Nelson
Publish date: September 15, 2017
HAPLO transplants may prove a better option than HLA-matched unrelated donor transplants.
News
- Author:
- Roxanne Nelson
Publish date: July 21, 2017
CHICAGO – Stress can push you to perform, but burnout just leaves you burnt.
News
- Author:
- Roxanne Nelson
Publish date: July 21, 2017
CHICAGO – “But burnout is a very slow and insidious process. A lot of the time we don’t recognize it. . ."
News
- Author:
- Roxanne Nelson
Publish date: July 19, 2017
Adjuvant therapy with girentuximab failed to improve either disease-free or overall survival, compared with placebo, in a cohort of patients in the...
